SYRE

NASDAQ · Biotechnology

Spyre Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$73.10

+0.10 (+0.14%)

As of May 9, 1:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +8.0% upside

Low Target $58.92

Average Target $78.92

High Target $128.60

Current Price $73.10

Current
$73.10

Target
$78.92

$58.92 $78.92 avg $128.60

Scenario Analysis

Bear Case

$58.92

-19.4%

Low target

Base Case

$78.92

+8.0%

Avg target

Bull Case

$128.60

+75.9%

High target

Risk/Reward

3.9x

Highly favorable

Price in Context

52-Week High

$76.00

-3.8% from high

52-Week Low

$12.29

+495.0% from low

50-Day SMA

$33.24

+119.9% vs SMA

200-Day SMA

$22.06

+231.4% vs SMA

RSI (14)

64.7

Neutral

Target vs 52W High

$78.92

+3.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%